The Efficacy of the Kyrobak for Chronic Low Back Pain (LBP-2)

Overview

The purpose of this study is to evaluate the efficacy of the Kyrobak continuous passive motion home-use device in relieving low back pain, improving proprioception (balance and fall prevention) and improving the symmetry of muscle function on either side of the spine.

Full Title of Study: “The Kyrobak Continuous Passive Motion Device for the Treatment of Chronic Low Back Pain: A Pilot Study”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 2013

Detailed Description

The Kyrobak is an electrically operated, continuous passive motion device including a platform that performs angular oscillations. The Kyrobak is used at home as an aid to relieve mild-to-moderate low back pain. The study is designed to evaluate the efficacy of daily home use of the Kyrobak for 3 weeks and to assess the sustained efficacy 1 week later. The evaluation will include the level of pain using the numerical rating scale (NRS), Digital Posturography, Heart Rate Variability (HRV), Static Surface Electromyography (SEMG), a condition-specific low back pain disability status by the Oswestry Disability Index (ODI) and subject satisfaction.

Interventions

  • Device: Continuous Passive Motion
    • Daily self-treatments at home for 3 weeks, with up to three 10-minute treatment sessions per day

Arms, Groups and Cohorts

  • Other: Treatment Continuous Passive Motion
    • Single-arm; 3-week treatment plan using Kyrobak compared to baseline (before treatment)

Clinical Trial Outcome Measures

Primary Measures

  • Change in Amount of Pain Determined by the NRS at the End of the 3-week Treatment Plan Compared to Baseline (Before Treatment)
    • Time Frame: 3 weeks
    • Pain level will be scored by the subject using the NRS on a 0 to 10 scale where 10 represents the highest level of pain and 0 represents no pain.

Secondary Measures

  • Change in Proprioception and Vestibular Function.
    • Time Frame: 3 weeks, 4 weeks
    • Gather information regarding: Balance and Fall Prevention using digital posturography
  • Change in Functional Health Status by ODI
    • Time Frame: 3 weeks, 4 weeks
    • Functional health status will be determined by the ODI questionnaire completed by the subject (based upon answers from 10 multiple choice questions)
  • Change in Symmetry of Muscle Function on Either Side of the Spine
    • Time Frame: 3 weeks, 4 weeks
    • Gather information regarding: Symmetry of muscle function about the spine using static surface electromyography (SEMG)
  • Change in Heart Rate Variability (and the Autonomic System)
    • Time Frame: 3 weeks, 4 weeks
    • Gather information regarding: Autonomic nervous system activity by measuring heart rate variability (HRV).

Participating in This Clinical Trial

Inclusion Criteria

  • Male or female, age 18 or older – Level of pain – mild to moderate low back pain (≤5 NRS pain) – Chronic – symptoms must have been present for at least 12 weeks or more. – Location – lower tip of scapula to back of pelvis – Etiology – non-specific Exclusion Criteria:

  • Patients who have low back pain due to specific and known causes (infection, tumor, osteoporosis, ankylosing spondylitis, fracture, inflammatory process, radicular syndrome (radiating nerve pain from the spine such as sciatica), cauda equinal syndrome (serious neurological disorder where the spinal nerve roots are compressed which can cause). – Weight in excess of 265 lbs. (120.4 kg) – Pregnant or breastfeeding – Recent history of violent trauma – History of previous back surgery – Constant progressive, non-mechanical pain (no relief with bed rest) – Chronic pain other than low back pain – Past medical history of malignant tumor – Has taken an investigational drug within the past 30 days prior to entering the study, or currently enrolled in another investigational study – Mental disorder that would lead to difficulty in questionnaire completion – Any litigation for low back pain – Prolonged use of corticosteroids (i.e. used for 3 months or more) – Present use of prescription pain medication (i.e. Percocet®, Oxycodone, Vicodin®, etc.) – Physical disability that prevents the subject to lie down/get up – Drug abuse, immunosuppression, HIV – Any other condition which in the physician's opinion would make it unsafe for the subject to be treated.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Radiancy
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Steven G Geanopulos, DC, Principal Investigator, New Heights Chiropractic

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.